Fiche publication
Date publication
septembre 2026
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERCEANU Ana
Tous les auteurs :
Coman T, Andreozzi F, Caudron A, Couturier MA, Landreau T, Tardieu L, Rejoul R, Marzloff M, Huynh A, Magro L, Chevallier P, Berceanu A
Lien Pubmed
Résumé
Continuous advances in allogeneic hematopoietic stem cell transplantation (allo-HSCT) have led to a growing population of long-term survivors. The Long-Term Follow-Up (LTFU) - typically defined as starting beyond two years post-transplant - aims to prevent, detect, and manage late complications, which progressively replace disease relapses as the leading cause of morbidity and mortality. Based on a literature review and a survey conducted among centers affiliated with the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), this workshop describes the current state of LTFU in French-speaking centers, the main categories of late toxicities, and the recommended strategies for prevention and screening. We propose a prioritization framework for the management of post-transplant complications, emphasizing the key roles of transplant physicians, organ specialists, general practitioners, nurse coordinators, and supportive care professionals. The recommendations highlight the need for a national framework to structure LTFU, ensure adequate financial recognition of its complexity, and strengthen the integration between hospital and community care to promote equity of access and high-quality survivorship care.
Mots clés
Allogreffe, Complication, Morbidity, Morbidité, Side effect, Transplantation
Référence
Bull Cancer. 2026 09 25;:
